Overview

DFN-11 Injection in Episodic Migraine With or Without Aura

Status:
Completed
Trial end date:
2018-02-26
Target enrollment:
Participant gender:
Summary
Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.
Phase:
Phase 3
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited